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Abstract   
Background: IgE-expressing (IgE+) plasma cells (PCs) provide a continuous source of allergen 
specific IgE that is central to allergic responses. The extreme sparsity of IgE+ cells in vivo has 
confined their study almost entirely to mouse models.  
Objective: To characterise the development pathway of human IgE+ PCs and to determine the 
ontogeny of human IgE+ PCs. 
Methods: To generate human IgE+ cells we cultured tonsil B cells with IL-4 and anti-CD40. Using 
FACS and RT-PCR we examined the phenotype of generated IgE+ cells, the capacity of tonsil B cell 
subsets to generate IgE+ PCs and the class switching pathways involved.  
Results: We have identified three phenotypic stages of IgE+ PC development pathway, namely (i) 
IgE+GC-like B cells, (ii) IgE+PC-like “plasmablasts”, and (iii) IgE+PCs. The same phenotypic stages 
were also observed for IgG1+ cells.  Total tonsil B cells give rise to IgE+ PCs by direct and sequential 
switching, whereas the isolated GC B cell fraction, the main source of IgE+ PCs, generates IgE+ PCs 
by sequential switching. PC differentiation of IgE+ cells is accompanied by down-regulation of 
surface expression of the short-form of membrane IgE (mIgES), which is homologous to mouse mIgE, 
and up-regulation of the long-form of mIgE (mIgEL), which is associated with enhanced B cell 
survival and expressed in humans but not in mice. 
Conclusion: Generation of IgE+ PCs from tonsil GC B cells occurs mainly via sequential switching 
from IgG. The mIgEL/mIgES ratio may be implicated in survival of IgE+ B cells during PC 
differentiation and allergic disease.  
 
Keywords: allergy, human B cells, IgE class switching, germinal center, plasma cell 
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Introduction  
IgE antibodies mediate the activation of IgE effector cells and antigen presenting cells by allergen and 
hence are central to allergic disease1,2. The increasing prevalence of allergic disease is alarming, yet 
little is known about the mechanisms of IgE regulation. The sparsity of IgE+ B cells in vivo has 
hindered attempts to investigate their development, particularly in the human system, while reliance 
on the results from mouse models often fails to predict the outcome of proposed therapies3.  
 
It is well established that T cell helper type 2 (Th2) cytokines, IL-4 and/or IL-13, in association with 
CD40 cross-linking on B cells, promote class switch recombination (CSR) to IgE, which may be 
direct, from IgM to IgE, or sequential, via IgG4. In vivo, CSR occurs in lymphoid tissues and at sites 
of inflammations5,6. In lymphoid tissue B cell-T cell interactions lead to B cell proliferation and the 
formation of germinal centres (GCs), in which CSR is accompanied by somatic hypermutation (SHM) 
in the variable regions, culminating in affinity maturation and selection of the B cells of highest 
affinity for antigen, or allergen in the case of IgE7,8. The selected cells may recycle via the T cell 
compartment or differentiate into memory B cells and PCs to enter circulation9,10.  
 
Recent studies in the mouse revealed that the fate of IgE+ B cells is dramatically different from that of 
IgG1+ B cells, which express the most abundant and most thoroughly investigated isotype11-16. It was 
shown that, although CSR to IgE is initiated in GCs, most of IgE+ cells exhibited a PC phenotype and 
were excluded from the GCs14. Likewise, other studies of IgE in the mouse showed that IgE responses 
are more transient than those of IgG1 and were predominantly directed into the PC lineage13. It was 
also reported that CSR pathway leading to IgE+ B cells determined their ultimate fate16. Direct 
switching gave rise to IgE+ GC cells with impaired B cell receptor (BCR) signalling, due to low 
expression of the BCR, leading to cell death16. This switching pathway was associated with the 
secretion of low affinity IgE antibodies16,17. In contrast, sequential switching generated IgE+ PCs with 
elevated BCR expression and was associated with secretion of high affinity IgE antibodies16,17. It was 
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inferred that the inheritance of SHM and affinity-maturation from IgG1+ B cells are needed for the 
generation of a memory IgE response17,18.  
The relevance of results in the mouse to human allergy has been questioned18. For example, human 
IgE+ B cells express two forms, one short and one long form, of mIgE, mIgES and mIgE L19,20. These 
mIgE isoforms arise from alternative splicing of a common mRNA precursor, with mIgEL containing 
a longer extra-membrane proximal domain (EMPD) region, an additional 52 amino acid residues 
between the C-terminal Ig domain, Cε4, and the transmembrane M1 domain19-21. Although nothing is 
yet known about the mechanisms that govern the relative expression of the two mIgE isoforms, there 
is evidence that the longer EMPD confers greater resistance to BCR-induced apoptosis21,22.  
 
We have previously characterized the capacity of various tonsil B cell subsets to undergo CSR to IgE 
ex vivo23. Using this ex vivo tonsil human B cell culture system we have now investigated the 
ontogeny of human IgE+ PCs. We point out many similarities, but also important differences from 
studies in the mouse models that may illuminate mechanisms in allergy.  
 
Methods 
Isolation of human tonsil B cells 
With informed written consent and ethical approval from Guy’s Research Ethics Committee, we 
obtained human tonsils from donors undergoing routine tonsillectomies. Mononuclear cells were 
separated according to density on a Ficoll gradient (GE Healthcare) and B cells isolated using 2-
aminoethylisothiouronium bromide-treated sheep red blood cells (TCS Biosciences). B cells were 
>95% CD19+ as determined by flow cytometry analysis.  
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Cell cultures 
To induce CSR to IgE, B cells were cultured as previously described23. Briefly, 0.5x106 freshly 
isolated tonsil B cells were stimulated with IL-4 (200IU/ml unless otherwise stated; R&D Europe 
Systems Ltd) and anti-CD40 antibody (0.5μg/ml unless otherwise stated;G28.5; American Type 
Culture Collection) for up to 12 days. 
 
FACS analysis 
Surface and intracellular staining of IgE+ cells was done as previously described23.  A detailed account 
of FACS analysis, cell sorting, RNA isolation, qRT-PCR and switch circle transcript PCR 
experiments can be found in the supplemental methods (available on the Allergy website).  
 
Statistical analysis 
Statistical analysis was performed using the One-Way ANOVA, with Bonferroni correction, unless 
otherwise stated. A value of P<0.05 was considered significant(*P< 0.05,**P< 0.01,***P< 0.001).  
 
Results  
Human IgE+ cells have three successive stages of differentiation into PCs 
To induce CSR to IgE we cultured freshly isolated human tonsil B cells with IL-4 and anti-CD40 
antibody. When staining for intracellular IgE we consistently observe two IgE+ cell populations (Fig. 
1A). We designate these IgElo and IgEhi cells.  Similarly, we observe two populations of IgG1+ cells, 
IgG1lo and IgG1hi cells. The ratio of IgEhi to IgElo rose from day 7 to day 12 in culture, whereas that of 
IgG1hi to IgG1lo cells remained constant (Fig. 1A and 1B). On profiling the surface markers of these 
cells, by FACS, we observed that both IgEhi and IgG1hi express lower levels of CD20, Fas, IL-4R and 
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Bcl-6, and higher levels of CD38, CD27 and Blimp-1 than IgElo and IgG1lo counterparts (Fig. 1C), 
indicating a more highly differentiated phenotype24.  
Two IgE+ cell populations were observed after immunization of mice and were characterized as IgE+ 
GC cells and IgE+ PCs13. However, unlike in mice, when staining the stimulated human B cells for 
CD138, a surface marker for the fully differentiated PCs, we observed three IgE+ cell populations: 
IgEloCD138-, IgEhi CD138-, and IgEhiCD138+ cells (Fig. 2A). 
 
To characterize in more detail the IgE+ cell populations along their differentiation pathway into PCs, 
we used a fixation and permeabilization FACS procedure25 to isolate RNA from sorted IgEloCD138-, 
IgEhiCD138- and IgEhiCD138+ cells.  For comparison we also sorted the IgG1+ cell counterparts. 
cDNA generated from these cells was used to quantify the relative expression levels of selected 
transcription factors known to be involved in maintaining the GC reaction and the B cell identity of 
the cells, or in inducing B cell differentiation towards PCs7,26. Fig. 2B compares these expression 
levels with those on the unstimulated tonsil GC B cell controls.  
 
Bcl-6 and Pax-5, important for maintaining the B cell identity and the GC phenotype7,26,27, are 
abundantly expressed in the GC B cells and the IgEloCD138-  and IgG1loCD138-  cells, but strongly 
down-regulated in both the IgEhi (IgEhiCD138- and IgEhiCD138+) and IgG1hi (IgG1hiCD138- and 
IgG1hiCD138+) cells (Fig. 2B). The opposite pattern is seen for Blimp-1 expression, an important 
factor of PC differentiation and function7,26,28. As the FACS-derived phenotype of these cells predicts, 
expression of the PC marker, CD138, is seen only in IgEhiCD138+ and IgG1hiCD138+ cells (Fig. 2B). 
There were, moreover, no discernible phenotypic differences between IgE+ and IgG1+ cells at 
different stages of differentiation. In addition, we find that as IgE+ and IgG1+ cells differentiate they 
down-regulate Ki-67 (Fig. S1), a marker of the proliferation, and their cell cycle progression declines, 
with the majority of the IgE+ and IgG1+ PCs being at the quiescent G0 stage of the cell cycle (Fig. S2).  
In sum, these observations, consistent with those on the cell surface markers, indicate that the IgElo 
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(IgEloCD138-) cells have a phenotype with GC B cell-like characteristics, whereas the IgEhi cells 
represent a later stage of differentiation into a PC-like (IgEhiCD138-) “plasmablast” phenotype, and 
only a small proportion appear to be fully differentiated PCs (IgEhiCD138+).  
 
Maintenance of GC B cells contributes to increased yields of IgE+ PCs 
In IL-4 and CD40 stimulated tonsil B cell cultures, B cells from the GC compartments are the main 
sources of IgE+ cells23. By comparison with naïve and memory B cells, these cells have very high 
rates of cell death, but also display elevated expression of IL-4R and CD4023.  We investigated the 
significance of these differences by stimulating human tonsil B cells with different IL-4 and anti-
CD40 concentrations.  Reducing the IL-4 concentration from 200 IU/ml (the level customarily used to 
stimulate CSR to IgE) to 100 IU/ml reduced the percentage of IgE+ cells (Fig. 3A,B), revealing that 
CSR to IgE is sensitive to the IL-4 concentration within this range of concentration. Increasing the 
concentration of IL-4 from 200 to 400 IU/ml caused no further accretion of IgE+ cells, but engendered 
a threefold increase in the proportion of IgE+ PCs (Fig. 3A,B,C). In contrast, these changes in IL-4 
concentrations did not affect IgG1+ cells (Fig. 3A,B,C). Neither IgE+ nor IgG1+ cells evinced any 
response to changes in anti-CD40 concentration (Fig. 3A,B,C). We also noted a significant reduction 
in the percentage of live cells cultured with 100 IU/mL of IL-4, and a marked enhancement in cultures 
with 400 IU/mL of IL-4 (Fig. 3D).   
 
This observation led - since GC B cells are the main source of IgE+ cells23- to the conjecture that the 
action of IL-4 may be restricted to the B cells from the GC compartments. To address this we sorted 
tonsil B cells into naïve (CD27-CD38-CD77-), memory (CD27+CD38-CD77-), early GC (CD27-
CD38+CD77+) and GC (CD27+CD38+CD77+) tonsil B cells23(Fig. S3) and cultured these cells with 
IL-4 and anti-CD40 (Fig.3E). Again, unlike anti-CD40, IL-4 exerted a concentration-dependent effect 
on GC-derived B cell cultures but not on naïve and memory B cell cultures (Fig.3E). The percentage 
of live cells in GC B cell cultures rose when the concentration of IL-4 was increased from 200 to 400 
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IU/mL (Fig.3E). We conclude that IL-4 contributes to the maintenance of the GC B cells and that the 
maintenance of these cells in culture results in higher yields of IgE+ PCs.  
 
Switched IgE+ cells from GC B cell cultures undergo rapid differentiation into IgE+ PCs. 
 The above results suggest that the GC environment may favour the generation of IgE+ PCs. To 
confirm this we cultured tonsil naïve, memory, eGC and GC B cells with IL-4 and anti-CD40, with 
unfractionated total B cells as controls, and determined the IgEhi/IgElo cell ratio as a measure of the 
rate of differentiation of the newly switched human IgE+ cells. We found that this ratio was lowest in 
naïve (0.19±0.14) and highest in GC B cell cultures (2.24±1.1), whereas the memory (0.95±0.59), 
eGC (1.18±0.64) and total B cell cultures (0.67±0.42) had IgEhi/IgElo cell ratios intermediate to that in 
the naïve and GC B cell cultures(Fig. 4A). IgG1+ cells, by contrast, despite their similar pattern of 
differentiation throughout the different B cell cultures (Fig. 4A), were predominantly 
IgG1lo(0.06±0.06 - 0.44±0.19).  
 
Examining the expression of Blimp-1 and Xbp-1, two important factors in PC differentiation and 
function7,26,28, before culture, we found that eGC and GC B cell fractions expressed significantly 
higher levels of Blimp-1(Fig. 4B and Fig. S4) and Xbp-1(Fig. 4B) than the other fractions. We 
hypothesized that the higher levels of Blimp-1 and Xbp-1 expression in eGC and GC B cells might 
predispose newly switched IgE+ cells, derived from these cells, towards the PC lineage. We therefore 
examined the PC differentiation of IgE+ cells in each of the sorted B cell cultures (Fig.4C).  
 
To account for the differences in CSR to IgE in these four different tonsil B cell fractions and the 
variability among the different tonsil B cell cultures23 we measured the yields of IgE+ PCs as a 
fraction of all IgE+ cells in each culture (Fig. 4D). We found that the GC B cell culture yielded the 
highest proportion of IgE+ PCs, and naïve B cell cultures yielded the lowest (Fig. 4C,D). Yet, despite 
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the higher expression of Blimp-1 and Xbp-1 expression in eGC compared to the memory cells, the 
two cell cultures yielded similar proportions of IgE+ PCs (Fig. 4C,D). The yields of IgE+ PCs in the 
unfractionated B cell cultures were between those in naïve and memory/ eGC B cell cultures (Fig. 
4C,D). These results show that elevated Blimp-1 and Xbp-1 expression cannot fully account for the 
rapid rate of PC differentiation. 
 
The difference in the yields of IgG1+ PCs between the various B cell cultures showed a similar pattern 
to the yields of IgE+ PCs (Fig. 4C,D). However, despite this, we find that the yields of IgG1+ PCs 
were much lower then those of IgE+ PCs. This is also evident in naïve B cell cultures, which have no 
IgG1+ cells at the start of the culture23, where the yields of IgE+ PCs are twice that of IgG1+ PCs (Fig. 
S5). The data demonstrate that IgE+ B cells have a much higher frequency of PC differentiation than 
IgG1+ cells.  
 
IgE+ PCs can be generated by both direct and sequential CSR 
Previous studies in the mouse demonstrated that sequential CSR to IgE from an IgG1+ B cell is 
required for the generation of high affinity IgE antibodies17. A follow-up report suggested that direct 
CSR from IgM to IgE generates IgE+ GC cells, and sequential CSR from IgG to IgE leads to IgE+ 
PCs16. To determine the relative importance of the CSR pathways to the generation of IgE+ cells in 
our total B cell cultures we examined switch circle transcripts (SCTs) by a nested PCR. Analysis of 
SCTs shows that both IgM to IgE  (Iε-Cμ) and IgG to IgE (Iε-Cγ) SCTs were present in IgEloCD138-, 
IgEhiCD138- and IgEhiCD138+ cells (Fig. 5A), revealing that both direct and sequential CSR can give 
rise to IgE+ GC B cells and IgE+ PCs.  
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Next we investigated the CSR pathways that generate IgE+ PCs in cultures of B cells from the GC and 
naïve compartments. We found that in GC B cell cultures both Iε-Cμ and Iε-Cγ SCTs were present in 
CD138- cells, but only Iε-Cγ SCTs in the CD138+ cells(Fig. 5B). In contrast, in naïve B cell cultures 
we detected both Iε-Cμ and Iε-Cγ SCTs in the CD138- and CD138+ cells (Fig. 5C). Overall, these 
data demonstrate that in human tonsil B cell cultures both direct and sequential CSR can give rise to 
IgE+ cells at all stages of differentiation. However, generation of IgE+ PCs from the GC-derived B 
cells appears to be selective, favouring sequential CSR to IgE. This may reflect the process of affinity 
maturation in IgG1+ GC B cells in vivo, leading to greater survival of cells expressing high affinity B 
cells, coordinated with CSR, and resulting in apoptosis of the less fit GC cells during ex vivo 
culture9,16,17,29,30. 
 
Modulation of surface IgE
 
expression along the differentiation pathway of IgE+ cells 
In mouse IgG1+ GC B cells, surface IgG1 is expressed at a 20-fold higher level than in IgG1+ PCs, 
whereas the opposite is true for the IgE+ cells13,16. When examining this phenomenon in human B 
cells it is necessary to recall that there are two isoforms of human mIgE, mIgEL and mIgES, the latter 
being homologous to the one in the mouse. Stimulated human B cells express a preponderance of the 
mIgEL isoform19-21. To determine the surface expression of the two mIgE isoforms along the 
differentiation pathway of human IgE+ B cells, we used a combination of two different anti-IgE 
antibodies. Staining with either a polyclonal anti-IgE, which recognizes all forms of IgE, or the anti-
IgE omalizumab, which recognizes only free IgE31, revealed that surface mIgE expression was higher 
in IgEhi than in IgElo cells (Fig.6A). The similarity of staining by these two antibodies excludes the 
possibility that free exogenous IgE is binding to the low affinity IgE receptor, CD23, expressed on the 
B cell membrane, consistent with our observation that surface expression of membrane CD23 is lower 
on IgEhi cells relative to IgElo cells (Fig. 6B). 
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Next, we determined the surface expressions of mIgE and mIgG1 at successive stages of IgE+ and 
IgG1+ cell differentiation, with the aid of, respectively, anti-IgE omalizumab and a polyclonal anti-
IgG1 (Fig. 6C,D). It can be seen that surface mIgG1 is down-regulated, and surface mIgE is up-
regulated in the course of PC differentiation in man, as in mouse13,16. Importantly, however, staining 
with anti-mIgEL, which recognizes only the mIgEL32, reveals a reduction in the surface mIgE on IgEhi 
cells relative to that on IgElo cells (Fig. 6A). This result was confirmed by the concomitant reduction 
in surface mIgEL along the differentiation pathway of IgE+ cells into PCs (Fig. 6E,F). 
In sum, our data provide evidence that the down-regulation of surface mIgEL is compensated by up-
regulation of surface mIgES, bearing in mind the elevated total surface mIgE expression.  
 
Discussion  
Most of the recent insights into the biology of IgE have come from studies in the mouse13-17,33. The 
primary aim of our work was to elucidate the developmental pathway of IgE+ PCs in the human 
system. A secondary aim was to compare the results obtained using tonsil B cells with those reported 
recently from various mouse models. 
 
The developmental pathway of human IgE+ cells can be resolved into three easily distinguishable 
stages, characterized as (i) IgE+ GC-like (IgEloCD138-), (ii) PC-like (IgEhiCD138-) “plasmablasts”, 
and (iii) IgE+ PCs (IgEhiCD138+). The same developmental sequence was seen to prevail in the human 
tonsil IgG1+ cells. In contrast, mouse in vivo and ex vivo studies show the existence of only two 
distinct IgE+ (IgEloCD138- and IgEhiCD138+) and IgG1+ (IgG1loCD138- and IgG1hiCD138+) cell 
populations13.  
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 In the mouse nascent IgE+ cells appeared to differentiate more swiftly into PCs than IgG1+ cells13,14, 
although this may have been their only route to survival16,33. Indeed, PC differentiation was the 
predominant fate of the mouse IgE+ cells in vivo as well as ex vivo13,14. Similarly, we show that, in the 
human system, a greater proportion of IgE+ cells, compared with their IgG1+ counterparts, 
differentiate into PCs. The mechanisms contributing to the apparent propensity of IgE+ cells to 
differentiate into the PC lineage remain unclear. 
 
The transgenic Blimp-1-deficient mouse B cells undergo CSR to IgE, but fail to differentiate into 
PCs13, confirming that Blimp-1 is not required for the CSR, but only for PC differentiation. However, 
Blimp-1 expression in our IgE+ and IgG1+ cells is similar and therefore does not account for their 
differences in PC differentiation. 
 Both mIgG1 and mIgE have cytoplasmic tails that contribute to their enhanced signalling capacity34-
38
. However, mIgE has a unique motif (YANIL-motif) within its cytoplasmic tail, which is not found 
in the cytoplasmic tails of IgG isotypes, and binds proteins such as HS-1 and HAX-139. This could 
potentially explain the enhanced PC differentiation of IgE+ cells. We have previously shown that 
CD23 plays an important role in IgE synthesis1. Therefore, the propensity of IgE+ cells towards the 
PC lineage could also result from the activity of CD23.  
 
An important way in which the mouse and human systems diverge is that whereas mouse IgEhi cells 
are mainly IgE+ PCs13,14, only a minor fraction of IgEhi cells in total tonsil B cells become CD138+ 
PCs. It is possible that in these cultures IgE+ PCs are generated but fail to survive. However, we have 
demonstrated that increased IL-4 concentration improved the yields of IgE+ PCs by maintaining the 
GC B cells. This implies that the GC B cells are important for the generation of IgE+ PCs and that IL-
4 is essential not only for CSR to IgE but also for the maintenance of GC B cells, which have very 
high rates of cell death23.  
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The high proportion of IgE+ cells that differentiated into IgE+ PCs at the end of the GC B cell cultures 
demonstrates the importance of GCs in the IgE+ PC generation. Yet, despite the different levels of 
Blimp-1 and Xbp-1 expression, eGC and memory B cell cultures display similar IgE+ cell propensity 
to PC differentiation, implying that other factor(s) are important, e.g. the response to cytokines that 
affect the balance between cell division and cell death. In contrast, the majority of IgE+ switched cells 
in naïve B cell cultures, which undergo similar levels of CSR to IgE23 and express similar levels of 
Blimp-1 and Xbp-1 to memory B cells, undergo a lower rate of PC differentiation. In vivo memory B 
cells are generated in GCs following SHM and affinity maturation, resulting in cells with high affinity 
BCRs12,13,48. The expression of a high affinity BCR is associated with the capacity for PC 
differentiation in the mouse29,30. 
A novel observation in the mouse was the inheritance of IgE memory from IgG+ cells17,18,20 and the 
different effects of direct and sequential switching on the fate of IgE+ cells15,16. The kinetics of B cell 
development revealed the relatively poor survival of IgE+ GC cells17,20, attributed to their low level of 
mIgE expression, and impaired BCR signalling17,20. The conclusion was that IgE+ GC cells fail to 
undergo the canonical B cell differentiation program that potentiates IgG1 memory immune 
responses16. The fate of the mouse IgE+ cells was determined by their switching pathway; direct 
switching from IgM+ cells generated only a transient population of IgE+ GC cells, whereas switching 
from IgG1+ cells generated IgE+ PCs, accompanied by the up-regulation of mIgE 16.  
 
In contrast to the results in the mouse, we observe that both direct and sequential CSR can give rise to 
IgE+ GC B cells and IgE+ PCs in our tonsil B cell cultures. This is supported by studies on a chimeric 
mouse model containing the human M1’ sequence inserted into a murine ε gene reporter construct12,15. 
Their IgE+ GC B cells were longer-lived than in other mouse models and able to differentiate into 
both IgE+ memory B cells and IgE+ PCs. Memory IgE+ B cells and IgE+ PCs can also be detected in 
the peripheral blood of humans40. We and others have attributed this to the M1’ sequence, which 
protects against apoptosis11,12,15,18.  
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Furthermore, we have also presented evidence of only sequential CSR in IgE+ PCs generated from the 
human GC-derived B cell cultures. The major implication of sequential CSR is the probability of 
affinity maturation of the IgG+ B cell precursors, by analogy to observations in the mouse18,20,21. It 
may follow that sequential CSR is the predominant route to IgE in allergic disease41. This is supported 
by the relative frequency of Iε-Cγ and Iε-Cμ transcripts in nasal biopsies from allergic rhinitis 
patients42 and bronchial biopsies from asthma patients43.  
 
Our experiments also reveal the modulation of the surface mIgEL and mIgES expression during PC 
differentiation. Earlier studies have shown that mIgEL and mIgES are the predominant isoforms in the 
IL-4 and anti-CD40 stimulated and unstimulated peripheral blood lymphocytes, respectively19-21. 
Therefore, the expression levels of the two mIgE isoforms during the PC differentiation may reflect 
the levels of signaling and proliferation induced by the IL-4 and anti-CD40 stimulations. Nonetheless, 
the above considerations suggest that the regulation of mIgEL expression is important for IgE 
homeostasis in the human system. Expression of this isoform is unique to man and could well be one 
reason why allergic disease occurs naturally in humans but apparently not in mice18. These data are of 
particular interest because the EMPD of surface mIgEL is a validated antibody target for 
immunotherapy of allergic disease, now under development in several laboratories with a view to 
therapeutic application32,44,45.  
 
In summary, using a tonsil ex vivo human system we have investigated the ontogeny of IgE+ B cells 
and IgE+ PCs. We believe that our results have direct relevance to the discovery of novel targets for 
treatment of allergy.  
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Figure Legends  
 
Figure 1. IgEhi cells have a more differentiated phenotype than IgElo B cells 
(A) Intracellular detection of two IgE+ and IgG1+ cell populations in our CSR to IgE cultures. Data 
are representative of 5 experiments. (B) The ratio of IgEhi to IgElo and IgG1hi to IgG1lo cells was 
calculated using the frequency of these cells on day 7 and 12 of culture. Data represent the mean +/- 
SD. *** P<0.001 (Two tailed t test). (C) Expression levels of CD20, CD27, CD38, Fas, IL-4R, Bcl-6 
and Blimp-1 on IgElo and IgG1lo (filled histogram) versus IgEhi and IgG1lo (empty histograms) gated 
cells, respectively. Data are representative of 6 experiments.  
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Figure 2. Human IgE+ and IgG1+ cells have three distinctive stages of differentiation into PCs 
(A) On day 10 of total B cultures, cells were surface stained for CD138 followed by 
fixation/permeabilisation and intracellular staining for IgE and IgG1. The FACS dot plots show three 
distinct IgE+ and IgG1+ cell populations; IgEloCD138-, IgEhiCD138-and IgEhiCD138+ and the 
respective IgG1+ cell counterparts. (B) The three IgE+ and IgG1+ cell populations were FACS sorted 
into RNA processing buffer. The isolated RNA from these sorted cells was then used to determine the 
expression levels of the GC B cell markers, Pax5, Bcl6, and PC markers, Blimp1 and CD138, by 
qRT-PCR. As controls we used RNA cells of the FACS sorted tonsil GC B cells. Data represent the 
mean +/- SEM and are derived from 4 different experiments. 
 
Figure 3. GC-derived B cells and the yields of IgE+ PC are sensitive to changes in IL-4 
concentration.  
To determine the effect of IL-4 and anti-CD40 concentrations on the generation of IgE+ cells, 
especially IgE+ PCs, tonsil B cells were cultured with varying concentrations of IL-4 and anti-CD40. 
(A) On day 10 of culture, cells were stained for IgE and CD138 (top panels) and IgG1 and CD138 
(bottom panels). The percentages of total IgE+ and IgG1+ cells (B), IgE+ and IgG1+ PCs (C), and % of 
live cell in culture (D), were made relative to the 200 IU/ml of IL-4 and 0.5 μg/ml of anti-CD40 
concentrations, standard concentrations used to induce CSR to IgE. (E) Percentage of live cells in 
cultures containing the FACS sorted naïve (CD19+CD27-CD38-), memory (CD19+CD27+CD38-), 
eGC (CD19+CD27-CD38+) and GC (CD19+CD27+CD38++). B cells cultured with increased 
concentrations of IL-4 (400 IU/ml) or anti-CD40 (1 μg/ml). The data show the fold changes in the 
percentage of live cells relative to the 200 IU/ml of IL-4 and 0.5 ug/ml of anti-CD40 cell culture 
condition and represent the mean +/- SD. *P < 0.05,**P < 0.01,***P < 0.001 (One way ANNOVA, 
Dunnett’s test) 
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Figure 4. GC B cell cultures yield the highest percentage of IgE+ PCs  
(A) Ratio of IgEhi to IgElo cells and IgG1hi to IgG1lo cells in IL-4 and anti-CD40 stimulated cultures of 
naïve, memory, eGC, GC and un-fractionated total B cells.  (B) Blimp-1 and Xbp-1 expression levels 
in sorted tonsil B cell subsets prior to culture with IL-4 and anti-CD40. Data represent the mean +/- 
SD and are derived from 3 different experiments. (C) FACS dot plots show the CD138 expression on 
IgE+ cells (top panels) and IgG1+ cells (bottom panels) after 10 days of culture with IL-4 and anti-
CD40. (D) Yields of IgE+ PCs (IgE+CD138+) and IgG1+ PCs (IgG1+CD138+) as a percentage of the 
total IgE+ and IgG1+ cells, respectively.   
 
Figure 5. Both direct and sequential switching generate IgE+ GC B cells and IgE+ PCs  
(A) RNA from the sorted IgEloCD138-, IgEhiCD138- and IgEhiCD138+ was used for the detection of 
Iε-Cμ SCT (167 bp; direct switching) and Iε-Cγ SCT (202 bp; sequential switching) by nested PCR. 
The PCR reactions were standardized by using equal amounts of RNA for the cDNA synthesis. 
CD138- and CD138+ cells were sorted from the IL-4 and anti-CD40 stimulated cultures of enriched 
GC (CD38+) B cells (B) and naïve B cell cultures (C). And RNA was used for the analysis of IgE 
switching pathway as above. As a positive control, cDNA from an IL-4 and anti-CD40 stimulated B 
cell culture that yielded high percentages of IgE+ cells was used, and as a negative control dH2O was 
used. (M= Marker). Data are representative of four different experiments. 
 
 Figure 6. Surface mIgE expression along the differentiation pathway of IgE+ cells 
(A) The FACS dot plot show the day 12 cultured cells surface stained for IgE with a polyclonal anti-
IgE, anti-IgE omalizumab and anti-mIgEL (4B12), followed by intracellular staining of IgE. Data are 
representative of 5 different experiments. (B) To determine the levels of membrane CD23 expression 
on IgElo and IgEhi cells on day 12 of the culture we surface stained for CD23, followed by fixation, 
permeabilisation and intracellular staining of IgE. The expression level of CD23 is shown as the fold 
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change in CD23 median fluorescence intensity (MFI), within the gated IgElo and IgEhi cells, relative to 
the CD23 MFI on IgElo cells. (C) The histograms show the surface levels of mIgE and mIgG1 
expression IgEloCD138-, IgEhiCD138-, IgEhiCD138+ and IgG1loCD138-, IgG1hiCD138-, 
IgG1hiCD138+, respectively.  (D) Summarized surface expression levels of mIgE and mIgG1 at 
different stages of differentiation into PCs. Expression levels (MFI) were made relative to the levels 
on the IgElo and IgG1lo gated cells. (E) The histogram shows the surface expression levels of mIgEL 
on IgEloCD138- (black line), IgEhiCD138- (blue line), and IgEhiCD138+ (red line). (F) Summarized 
surface expression levels of mIgEL made relative to the expression levels on IgEloCD138- gated cells. 
Data represent the mean +/- SD. *P < 0.05,**P < 0.01,***P < 0.001 (One way ANNOVA, Dunnett’s 
test). 
 
Abbreviations 
 
BCR           B cell receptor 
eGC            Early germinal center  
EMPD        Extra-membrane proximal domain 
CSR            Class switch recombination 
FACS         Flow cytometry or fluorescence-activated cell sorting 
GC              Germinal Center 
mIgES           Short form  membrane IgE 
mIgEL           Long form  membrane IgE 
PB              Plasma blast 
PC              Plasma cells 
SHM          Somatic hyper mutations 
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